Independent Medical Education (IME)

Organization
Genentech
Type
Foundation
Comments
Grant requests must be submitted at least 60 days prior to the project/program start date. 
Brief Description

Genentech/Roche supports grants for independent medical education in an effort to further the advance of medicine and healthcare by improving the knowledge of the medical community.

Independent Medical Education (IME) is generally defined as education for healthcare professionals (HCPs) provided by an independent educational provider, such as a community hospital, academic center, society/association or medical education & communication company.

Grant requests must be submitted at least 60 days prior to the project/program start date. 

Genentech/Roche will consider funding requests in the following disease states:

  • Acute Myeloid Leukemia
  • Age-Related Macular Degeneration
  • Allergy
  • Asthma
  • Basal Cell Carcinoma
  • Bladder Cancer
  • Breast Cancer (Multiple Subtypes)
    • HER2-Positive
  • Diabetic Macular Edema
  • Diabetic Retinopathy
  • Geographic Atrophy
  • Giant Cell Arteritis
  • Hematologic Malignancy (Multiple Malignancies)
    • Lymphoma
      • Diffuse Large B-Cell
      • Follicular
      • Non-Hodgkins
    • Leukemia
      • Acute Myeloid
      • Chronic Lymphocytic
    • Myeloma
  • Hemophilia
  • Hepatocellular Carcinoma
  • Huntington's Disease
  • Idiopathic Pulmonary Fibrosis
  • Influenza
  • Lung Cancer (Multiple Subtypes)
    • Non-Small-Cell
    • Non-Small Cell ALK Positive
    • Non-Small Cell RET Altered
    • Non-Small Cell ROS1 Positive
    • Small-Cell
  • Melanoma
  • Multiple Sclerosis
  • Nasal Polyps
  • Neuromyelitis Optica
  • NTRK Fusion Cancers
  • Pan-Tumor
  • Pemphigus Vulgaris
  • Prostate Cancer
  • Retinal Vein Occlusion
  • Rheumatoid Arthritis
  • Scleroderma
  • Spinal Muscular Atrophy
  • Stroke
  • Thyroid Cancer RET Altered
  • Vasculitis